Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14629803 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients
Conditions: Contrast Induced Nephropathy;   Acute Renal Failure
Intervention:

Indicates status has not been verified in more than two years